Viewing Study NCT06142058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-02-23 @ 12:22 PM
Study NCT ID: NCT06142058
Status: RECRUITING
Last Update Posted: 2023-11-21
First Post: 2023-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
Sponsor: Xueqin Yang
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Evaluation View
None NSCLC View
None Targeted Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tumor marker View
None NSCLC View
None RECIST View
None RecistTM View
None positive driving gene View